Catia Giordano Selected Research

Hyperalgesia

6/2014	Dorsal striatum metabotropic glutamate receptor 8 affects nocifensive responses and rostral ventromedial medulla cell activity in neuropathic pain conditions.
3/2013	Role of metabotropic glutamate receptor 1 in the basolateral amygdala-driven prefrontal cortical deactivation in inflammatory pain in the rat.
11/2012	5'-Chloro-5'-deoxy-(±)-ENBA, a potent and selective adenosine A(1) receptor agonist, alleviates neuropathic pain in mice through functional glial and microglial changes without affecting motor or cardiovascular functions.
11/2012	TRPV1-dependent and -independent alterations in the limbic cortex of neuropathic mice: impact on glial caspases and pain perception.
4/2011	The galactosylation of N(ω)-nitro-L-arginine enhances its anti-nocifensive or anti-allodynic effects by targeting glia in healthy and neuropathic mice.
1/2009	A single subcutaneous injection of ozone prevents allodynia and decreases the over-expression of pro-inflammatory caspases in the orbito-frontal cortex of neuropathic mice.
3/2008	Involvement of subtype 1 metabotropic glutamate receptors in apoptosis and caspase-7 over-expression in spinal cord of neuropathic rats.
2/2007	Role of reactive oxygen species and spinal cord apoptotic genes in the development of neuropathic pain.
10/2006	Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Catia Giordano Research Topics

Disease

10	Neuralgia (Stump Neuralgia) 06/2014 - 10/2006
9	Hyperalgesia 06/2014 - 10/2006
5	Pain (Aches) 03/2013 - 03/2011
2	Autism Spectrum Disorder 07/2012 - 01/2012
1	Tobacco Use Disorder (Nicotine Dependence) 01/2019
1	Brain Concussion (Cerebral Concussion) 01/2017
1	Autistic Disorder (Autism) 11/2013
1	Hypersensitivity (Allergy) 03/2013
1	Chronic Pain 03/2013
1	Inflammation (Inflammations) 01/2012
1	Visceral Pain 04/2011
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2009
1	Gliosis 03/2008

Drug/Important Bio-Agent (IBA)

4	Glutamic Acid (Glutamate)FDA Link 03/2013 - 03/2008
3	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 06/2014 - 03/2011
3	CarrageenanIBA 03/2013 - 03/2011
3	CaspasesIBA 11/2012 - 01/2009
3	Analgesics (Analgesic Drugs)IBA 01/2012 - 03/2008
2	metabotropic glutamate receptor 8IBA 06/2014 - 03/2011
2	gamma-Aminobutyric Acid (GABA)IBA 03/2013 - 03/2011
2	EndocannabinoidsIBA 01/2012 - 10/2006
2	Serotonin (5 Hydroxytryptamine)IBA 03/2011 - 10/2006
2	Messenger RNA (mRNA)IBA 01/2009 - 02/2007
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	AmidesIBA 01/2019
1	palmidrolIBA 01/2017
1	CB2 Cannabinoid ReceptorIBA 11/2013
1	Zoledronic Acid (Zometa)FDA Link 03/2013
1	Liposomes (Liposome)IBA 03/2013
1	BicucullineIBA 03/2013
1	metabotropic glutamate receptor type 1IBA 03/2013
1	PlasticsIBA 03/2013
1	GABA-A Receptors (GABA(A) Receptor)IBA 03/2013
1	Adenosine (Adenocard)FDA LinkGeneric 11/2012
1	1,3-dipropyl-8-cyclopentylxanthineIBA 11/2012
1	Purinergic P1 Receptor AntagonistsIBA 11/2012
1	AMPA Receptors (AMPA Receptor)IBA 11/2012
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2012
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 11/2012
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2012
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2012
1	KaolinIBA 01/2012
1	ProstaglandinsIBA 01/2012
1	Nerve Growth Factors (Neurotrophins)IBA 12/2011
1	ProdrugsIBA 04/2011
1	EstersIBA 04/2011
1	Arginine (L-Arginine)FDA Link 04/2011
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 04/2011
1	Monosaccharide Transport ProteinsIBA 04/2011
1	vesicular GABA transporterIBA 03/2011
1	Proteins (Proteins, Gene)FDA Link 03/2011
1	Neurotransmitter Agents (Neurotransmitter)IBA 03/2011
1	OzoneIBA 01/2009
1	Caspase 3 (Caspase-3)IBA 01/2009
1	Caspase 8 (Caspase-8)IBA 01/2009
1	Caspase 12IBA 01/2009
1	(3,4- dihydro- 2H- pyrano(2,3)b- quinolin- 7- yl)- (cis- 4- methoxycyclohexyl) methanoneIBA 03/2008
1	1-aminoindan-1,5-dicarboxylic acidIBA 03/2008
1	Ionotropic Glutamate ReceptorsIBA 03/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2007
1	Caspase 9IBA 02/2007
1	phenyl-N-tert-butylnitroneIBA 02/2007
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 10/2006
1	Mesylates (Mesylate)IBA 10/2006
1	N-(4-hydroxyphenyl)arachidonylamide (AM404)IBA 10/2006
1	Cannabinoid Receptor AgonistsIBA 10/2006
1	anandamide (arachidonylethanolamide)IBA 10/2006
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 10/2006
1	5-HT1A Serotonin ReceptorIBA 10/2006
1	CannabinoidsIBA 10/2006

Therapy/Procedure

2	Therapeutics 01/2012 - 03/2008
1	Subcutaneous Injections 01/2009
1	Operative Surgical Procedures 01/2009